Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant.

Steenland K, Tinker S, Frisbee S, Ducatman A, Vaccarino V.

Am J Epidemiol. 2009 Nov 15;170(10):1268-78. doi: 10.1093/aje/kwp279. Epub 2009 Oct 21.

PMID:
19846564
2.

Tenuous dose-response correlations for common disease states: case study of cholesterol and perfluorooctanoate/sulfonate (PFOA/PFOS) in the C8 Health Project.

Kerger BD, Copeland TL, DeCaprio AP.

Drug Chem Toxicol. 2011 Oct;34(4):396-404. doi: 10.3109/01480545.2011.582502. Epub 2011 Jul 19. Review.

PMID:
21770727
3.

Distributions of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in Japan and their toxicities.

Nakayama S, Harada K, Inoue K, Sasaki K, Seery B, Saito N, Koizumi A.

Environ Sci. 2005;12(6):293-313. Review.

PMID:
16609670
4.

Contamination, bioaccumulation and toxic effects of perfluorinated chemicals (PFCs) in the water environment: a review paper.

Suja F, Pramanik BK, Zain SM.

Water Sci Technol. 2009;60(6):1533-44. doi: 10.2166/wst.2009.504. Review.

PMID:
19759456
5.

[Perfluorooctane sulfonic acid and perfluorooctanoic acid].

Minoia C, Leoni E, Sottani C, Biamonti G, Signorini S, Imbriani M.

G Ital Med Lav Ergon. 2008 Oct-Dec;30(4):309-23. Review. Italian. No abstract available.

PMID:
19344082
6.

Differential toxicity between perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA).

Tsuda S.

J Toxicol Sci. 2016;41(Special):SP27-SP36. doi: 10.2131/jts.41.SP27. Review.

7.

Exposure to PFOA and PFOS and fetal growth: a critical merging of toxicological and epidemiological data.

Negri E, Metruccio F, Guercio V, Tosti L, Benfenati E, Bonzi R, La Vecchia C, Moretto A.

Crit Rev Toxicol. 2017 Jul;47(6):482-508. doi: 10.1080/10408444.2016.1271972. Epub 2017 Feb 15. Review.

PMID:
28617200
8.

[Characteristics, use and toxicity of fluorochemicals: review of the literature].

Negri S, Maestri L, Esabon G, Ferrari M, Zadra P, Ghittori S, Imbriani M.

G Ital Med Lav Ergon. 2008 Jan-Mar;30(1):61-74. Review. Italian.

PMID:
18700679
9.

Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha.

DeWitt JC, Shnyra A, Badr MZ, Loveless SE, Hoban D, Frame SR, Cunard R, Anderson SE, Meade BJ, Peden-Adams MM, Luebke RW, Luster MI.

Crit Rev Toxicol. 2009;39(1):76-94. doi: 10.1080/10408440802209804 . Review.

PMID:
18802816
10.

Immunotoxicity of perfluorinated compounds: recent developments.

DeWitt JC, Peden-Adams MM, Keller JM, Germolec DR.

Toxicol Pathol. 2012;40(2):300-11. doi: 10.1177/0192623311428473. Epub 2011 Nov 22. Review.

PMID:
22109712
11.

A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans.

Chang ET, Adami HO, Boffetta P, Cole P, Starr TB, Mandel JS.

Crit Rev Toxicol. 2014 May;44 Suppl 1:1-81. doi: 10.3109/10408444.2014.905767. Epub 2014 May 5. Review.

PMID:
24793953
12.

Recent experimental results of effects of perfluoroalkyl substances in laboratory animals - Relation to current regulations and guidance values.

Lilienthal H, Dieter HH, Hölzer J, Wilhelm M.

Int J Hyg Environ Health. 2017 Jun;220(4):766-775. doi: 10.1016/j.ijheh.2017.03.001. Epub 2017 Mar 2. Review.

PMID:
28286084
13.

Perfluorinated Alkyl Substances: Emerging Insights Into Health Risks.

Grandjean P, Clapp R.

New Solut. 2015 Aug;25(2):147-63. doi: 10.1177/1048291115590506. Epub 2015 Jun 17. Review.

PMID:
26084549
14.

Ecotoxicological evaluation of perfluorooctanesulfonate (PFOS).

Beach SA, Newsted JL, Coady K, Giesy JP.

Rev Environ Contam Toxicol. 2006;186:133-74. Review.

PMID:
16676904

Supplemental Content

Support Center